Research

Stem Cell Research and Safety

Commitment to Clinical Excellence and Scientific Integrity

At AMS Asia, we are dedicated to pioneering regenerative medicine through robust scientific validation, meticulous quality assurance, and adherence to global safety standards. Our advanced biotechnology platform facilitates access to rigorously tested and clinically validated mesenchymal stem cell (MSC) therapies, designed to ensure optimal patient outcomes with the highest safety and efficacy standards.

Understanding Mesenchymal Stem Cells (MSCs)

Mesenchymal Stem Cells are multipotent stromal cells with the unique capability to differentiate into various cell types such as osteoblasts, chondrocytes, adipocytes, and myocytes. More critically, MSCs exert significant therapeutic benefits through immunomodulation, paracrine signaling, and anti-inflammatory properties. These mechanisms are fundamental to their wide-ranging clinical applications.

Comprehensive Safety Profile

Our MSC therapies are supported by extensive research, including a comprehensive meta-analysis that evaluated:

This robust body of research consistently demonstrates minimal adverse events, low immunogenicity, absence of tumorigenesis, and a high degree of clinical safety when MSC therapies are properly administered.

Clinical Applications

AMS Asia utilizes MSC therapies across a broad spectrum of clinical applications, thoroughly documented by scientific literature and clinical trial evidence:
 

Musculoskeletal and Orthopedic

• Osteoarthritis (knee, hip, shoulder)

• Intervertebral disc degeneration

• Rheumatoid arthritis and inflammatory joint conditions

• Tendon, ligament, and soft tissue repair
   

Neurological and Neurodegenerative Disorders

• Stroke rehabilitation (ischemic and hemorrhagic)

• Multiple sclerosis (immune modulation and remyelination support)

• Parkinson’s and Alzheimer’s diseases (neuronal support and inflammation reduction)

• Traumatic spinal cord and brain injuries

• Autism Spectrum Disorders (immune modulation)
   

Cardiovascular and Pulmonary

• Post-myocardial infarction cardiac repair

• Chronic heart failure management

• Peripheral artery disease (angiogenesis promotion)

• COPD, pulmonary fibrosis, and pulmonary hypertension
   

Autoimmune and Inflammatory Conditions

• Graft-versus-host disease (GVHD)

• Systemic lupus erythematosus (SLE)

• Crohn’s disease and ulcerative colitis

• Type 1 diabetes (beta-cell preservation and immune modulation)
   

Hepatic and Renal Disorders

• Liver cirrhosis (viral, alcoholic, non-alcoholic steatohepatitis)

• Chronic kidney disease and diabetic nephropathy
   

Endocrine and Metabolic Health

• Type 2 diabetes mellitus (islet cell function restoration)

• Polycystic ovary syndrome (fertility and hormonal balance)

• Male infertility and erectile dysfunction (vascular and hormonal rejuvenation)
   

Dermatological and Cosmetic Applications

• Chronic wound healing and diabetic ulcer treatment

• Scar reduction and skin regeneration

• Alopecia and hair follicle regeneration

• Aesthetic rejuvenation (skin elasticity and hydration)

Advanced Manufacturing and Quality Standards

Our regenerative therapies strictly adhere to international Good Manufacturing Practice (GMP) guidelines, ISO 14644 cleanroom standards, and FDA-aligned Chemistry, Manufacturing, and Controls (CMC) procedures:

Patient-Centric Safety and Monitoring Protocols

AMS Asia’s therapeutic protocols include comprehensive patient safety frameworks:

• Pre-Treatment Diagnostics: Detailed immune profiling, cytokine assessments, metabolic and hormonal evaluations.

• Continuous Monitoring: On-going assessment during treatment, capturing biological markers and clinical responses.

• Long-Term Safety Monitoring: Structured post-treatment follow-ups, including biological evaluations and clinical outcome tracking.

• Patient Registry and Data Transparency: Commitment to transparency through detailed record-keeping and registry reporting for long-term safety and efficacy analyses.

Why Choose AMS Asia?

We are neither a traditional clinic nor a therapy distributor; AMS Asia stands as a biotech innovator and trusted healthcare coordination platform. We connect patients and healthcare providers to a global network of clinical excellence across Southeast Asia and beyond, including countries like Thailand, Malaysia, Singapore, Indonesia, Japan, Vietnam, Cambodia, and select European nations.

Our distinct offerings include:

• Proprietary diagnostic approach (Health Blueprint™) for personalized regenerative treatments.

• Comprehensive logistics and patient support, from travel and treatment coordination to follow-up care.

• Adherence to international regulatory and ethical standards ensuring the highest quality of care.

Stem cell therapies represent the frontier of modern medicine, delivering transformative outcomes based on rigorous scientific research and proven clinical safety. AMS Asia proudly offers access to these advanced regenerative treatments, supported by an unwavering commitment to patient safety, clinical excellence, and scientific integrity.

We invite healthcare professionals, institutions, and informed patients to explore the comprehensive benefits of MSC therapy and experience regenerative medicine at its highest standard with AMS Asia.